临时机械循环支持状态2候选者中正性肌力支持与持久LVAD植入率低
结果显示,仅7.2%在tMCS前使用符合状态3标准的正性肌力药,状态2后6周内持久LVAD累积植入率为2.7%(95%CI 2.6%-2.9%),且中心间差异显著。
要点
- tMCS前符合状态3的正性肌力支持率仅7.2%。
- 状态2后6周内持久LVAD累积植入率2.7%。
- 正性肌力支持率和LVAD植入率中心间差异显著(p<0.001)。
核心结论
- 美国心脏移植中心很少在启动tMCS前报告符合状态3标准的正性肌力支持,且不常规将状态2的tMCS患者过渡至持久LVAD。
主要发现
- tMCS前符合状态3标准的正性肌力支持报告率为7.2%。
- 状态2后6周内持久LVAD累积植入率为2.7%(95%CI 2.6%-2.9%)。
- 正性肌力支持率中心间范围0%-38.8%(p<0.001),持久LVAD植入率中心间范围0%-33.3%(p<0.001)。
临床怎么用
- 提示当前美国实践中,状态2的tMCS患者较少在tMCS前接受符合状态3的正性肌力支持,且较少在6周内过渡至持久LVAD,中心间差异显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: After the 2018 heart allocation policy change, status 2 listings with temporary mechanical circulatory support (tMCS) have increased while listings with durable left ventricular assist devices (LVADs) have decreased. Treatment of cardiogenic shock varies geographically, but how often patients with status 2 are supported by inotropes before tMCS and receive durable LVADs is unknown. METHODS: Using the Scientific Registry of Transplant Recipients, we identified all adult heart transplant candidates who received an intra-aortic balloon pump (IABP) or percutaneous endovascular ventricular assist device (PEVAD) between October 18, 2018 and December 31, 2023 and subsequently obtained status 2. We assessed the rate of overall utilization and between-center variation in use of a priori inotropic support meeting status 3 criteria and durable LVAD implantation within 6 weeks after receiving status 2. RESULTS: During the study period, 6,010 patients with tMCS obtained status 2 (PEVADs: n = 1,957; IABPs: n = 4,053). Transplant centers reported use of inotropes meeting status 3 criteria in 7.2% of patients before IABP or PEVAD placement. The cumulative incidence of durable LVAD implantation within 6 weeks after obtaining status 2 was 2.7% (95% confidence interval [2.6%, 2.9%]). Reported rates of inotropic support before tMCS and durable LVAD implantation varied significantly by US transplant center (0%-38.8%, p < 0.001% and 0%-33.3%, p < 0.001, respectively). CONCLUSIONS: US heart transplant centers rarely report supporting candidates with inotropes meeting status 3 criteria before initiating tMCS and do not routinely transition patients with status 2 for tMCS to durable LVAD support.
引用
- Ahn DJ, White M, Ran G, et al. Low rates of inotropic support and durable left ventricular assist device placement among status 2 heart transplant candidates with temporary mechanical circulatory support. J Heart Lung Transplant. 2025. PMID: 41241033. doi:10.1016/j.healun.2025.11.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。